UI Pharmaceuticals offers a strong lyophilization cycle development expertise. Let us help you identify appropriate processing parameters for your product.
Clinical Supply Manufacturing

Lyophilization Cycle Development


Clinical Supply Manufacturing


Small Scale Commercial Manufacturing


Analytical Method Development and Validation


Routine Quality Control Analysis


Stability Assessment


Formulation Development


Comparator Products


Powder in a Bottle


Preformulation Studies


Active Pharmaceutical Ingredient (API) and Excipient Release Testing


QP Release Services


Lyophilization cycle development

Freeze Drying Microscope

UI Pharmaceuticals’ Scientists have extensive experience with lyophilization and lyophilization cycle development. With the installation of a new Lyotherm 2 and Lyostat 2, UIP has significantly enhanced its lyophilization cycle development capabilities.

The Lyotherm 2 provides UIP with an integrated Differential Thermal Analyser (DTA) and electrical impedance (Zsinφ) capability in a single instrument. This allows measurement of glass transition (Tg'), eutectic (Teu) and melting (Tm) temperatures relevant to freeze-drying formulations.

The Lyostat 2 is a fully integrated freeze-drying microscope that enables critical events, such as collapse and melting, to be observed in situ, as well as characteristics such as skin or crust formation to be observed and identified.

The coupled Lyostat 2 and Lyotherm 2 units provide valuable information for both formulation and lyophilization cycle development processes. With UIP's in-house expertise, the purchase of this system will allow quicker and more efficient development of lyophilization cycles.

For more information about our lyophilization cycle development capabilities, please Contact Us.